Epidemiological studies in mucus hypersecretion.
Respiratory mucus in epidemiology has mainly been studied using standardized questionnaires including questions on cough and phlegm. In chronic obstructive pulmonary disease (COPD) much controversy exists regarding the importance of mucus hypersecretion. From being the key element in the 'British hypothesis' it was reduced to being an innocent disorder in the 1980s but is now again recognized as a potential risk factor for an accelerated loss of lung function. Whereas early studies in mainly occupational cohorts showed no effect of chronic mucus hypersecretion on decline in lung function, such an effect has been shown in subsequent studies on general population samples. Chronic mucus hypersecretion also increases risk of hospital admission which may be due to an increased risk of lower respiratory tract infection. In severe COPD this may explain the increased mortality associated with the presence of mucus. In asthma recent findings suggest that in epidemiology chronic mucus hypersecretion may indicate lack of control which leads to an accelerated loss of lung function and increased mortality in subjects with self-reported asthma.
Vestbo
Jørgen
J
Department of Respiratory Medicine, Hvidovre University Hospital, Kettegaard Alle 30, Hvidore, DK-2650, Denmark.
D000328:Adult; D000368:Aged; D015331:Cohort Studies; D005088:Exocrine Glands / Q000378:metabolism; D005089:Exocytosis; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D009093:Mucus / Q000378:metabolism*; D009784:Occupational Diseases / Q000503:physiopathology; D029424:Pulmonary Disease, Chronic Obstructive / Q000401:mortality / Q000503:physiopathology; D012140:Respiratory Tract Diseases / Q000503:physiopathology*; D012306:Risk; D012307:Risk Factors; D012636:Secretory Rate